If you’ve ever sat across from a patient in a clinic, listening as they described years of tight chest pain that left them too breathless to walk up a single flight of stairs, you know cardiovascular disease (CVD) isn’t just numbers on a lab report. It’s the story of a mom who can’t chase her kid to the bus stop, a retiree who can’t tend to the garden they’ve nurtured for decades, and a neighbor who feels like their body is betraying them for no clear reason. As someone who’s spent years working in cardiovascular supply—partnering with clinics, hospitals, and care teams to get the tools they need to treat CVD—one conversation that keeps coming up, again and again, is how race shapes that risk story. It’s not about biology as a fixed, unchangeable truth. It’s about the layers of systemic barriers, social determinants of health, and even unrecognized biases that stack the deck against millions of people, and it’s a conversation we can’t afford to ignore. Cardiovascular

Let’s start with the numbers, because they tell a story no single patient’s experience can. The Centers for Disease Control and Prevention (CDC) reports that Black adults in the U.S. have a 30% higher rate of heart disease than white adults, and their risk of dying from a heart attack is nearly 20% higher. For Hispanic or Latino adults, the picture is a bit more nuanced: they often have lower rates of CVD than white adults overall, but they’re more likely to develop CVD at a younger age, and they face steeper barriers to getting timely care. Indigenous people, too, bear a disproportionate burden: the Indian Health Service notes that CVD is the leading cause of death for Indigenous populations, with rates 20% higher than the general U.S. population. These aren’t random stats. They’re reflections of how race, as a social construct, intersects with every part of a person’s life to shape their heart health.
First, there’s the gap in access to consistent, high-quality care, and that gap is rooted in systemic racism. For generations, redlining policies—once official government practice, now embedded in community design—drew lines that kept Black, Indigenous, and people of color (BIPOC) neighborhoods underserved by clinics, hospitals, and primary care providers. A 2022 study in the Journal of the American College of Cardiology found that neighborhoods that were redlined in the 1930s still have 25% fewer cardiology practices today than neighborhoods that were graded “A” (the highest, most privileged grade). If you can’t get to a cardiologist when you notice symptoms, if you can’t afford to take a day off work for a screening, or if you’re told your chest pain is “just stress” for years before it’s diagnosed as CVD, that delay can turn a manageable condition into a life-threatening one.
It’s not just access to care—it’s the quality of care once you get there. Implicit bias among healthcare providers is a well-documented issue, and it hits BIPOC patients hard. Studies have shown that Black patients are less likely to be prescribed evidence-based CVD medications like statins or beta-blockers, even when their symptoms and lab results match the guidelines. A 2021 report from the American Heart Association found that Black adults with high blood pressure are twice as likely to have their condition poorly controlled as white adults, in part because providers are less likely to prescribe the right combination of medications or follow up to make sure the treatment is working. For Indigenous patients, language barriers and a history of harmful medical exploitation have created mistrust that leads many to delay seeking care entirely, which only worsens their CVD risk over time.
Then there are the social determinants of health, the everyday factors that shape how your body functions from childhood onward. Food insecurity, for example, is a major driver of high blood pressure, high cholesterol, and obesity—all key CVD risk factors. BIPOC communities are far more likely to live in “food deserts,” areas without easy access to fresh fruits, vegetables, and whole grains, where the only grocery stores are miles away and corner stores sell mostly processed, high-sodium foods. A 2020 study in Circulation found that Black adults are 50% more likely to live in a food desert than white adults, and that extra sodium in their diets over a lifetime raises their risk of hypertension, a leading cause of heart attack and stroke.
Housing stability is another factor. Unsafe housing, overcrowding, and lead exposure (common in older homes in low-income BIPOC neighborhoods) have been linked to higher rates of inflammation in the body, a process that contributes to CVD. Chronic stress from experiencing racism—what researchers call “racism-related stress”—is a silent, constant burden for many BIPOC people. Every time you face a microaggression, every time you’re profiled by police, every time you have to work twice as hard to get the same respect as a white colleague, your body stays in a state of high alert. That chronic stress raises cortisol levels, spikes blood pressure, and over time, damages blood vessels—all of which directly increase CVD risk. It’s a invisible load that no lab test can pick up, but that shapes every part of a person’s health.
It’s important to note that race is not a biological cause of CVD. There’s more genetic variation within a single racial group than there is between different groups, and genetics only account for a small portion of overall CVD risk. What looks like a “racial difference” in heart health is almost always a reflection of how society treats different groups, not inherent traits of their bodies. For example, the higher rate of kidney disease in Black adults, which is a major contributor to CVD, isn’t caused by their race—it’s caused by decades of limited access to kidney care, higher rates of hypertension from unmanaged stress and poor diet, and systemic barriers that make it harder to get screened early.
That’s why, for our team in cardiovascular supply, this conversation isn’t just about data—it’s about responsibility. We don’t just sell stents or blood pressure monitors or EKG machines; we partner with care teams to make sure those tools reach the communities that need them most. Over the last five years, we’ve worked with community health centers in Atlanta, Houston, and Phoenix—areas with large BIPOC populations—to design programs that bring screenings and preventive care to people who might otherwise never see a cardiologist. We’ve donated portable EKG units so that mobile clinics can set up in church basements, housing projects, and job sites, instead of only in hospital buildings that are hard to reach. We’ve also trained our own team to listen to the unique needs of these communities, because we know that a one-size-fits-all approach to CVD doesn’t work.
For example, a patient in a rural Indigenous community in Arizona might not have access to a pharmacy that carries their heart medication, so we work with local care teams to set up medication delivery programs that use trusted community partners to get pills to their door. A single mom in Chicago who works two jobs might not have time to go to a clinic for a follow-up appointment, so we help set up virtual monitoring tools that let her track her blood pressure at home and share the data with her cardiologist, no travel required. These aren’t just nice gestures—they’re practical steps that address the gaps created by systemic barriers.
But we know there’s still so much more to do. One of the biggest challenges we face is that many CVD guidelines and risk calculators are based on research that was done mostly on white, male patients, so they don’t accurately predict risk for BIPOC groups. For example, the common ASCVD risk score underestimates heart attack risk for Black women, leading some care teams to delay preventive treatments that could save lives. That’s why we invest in partnering with researchers and community leaders to adapt these tools, to make sure they’re accurate for the diverse patients care teams serve every day.
As someone who’s been in this field for over a decade, I’ve seen too many patients whose heart health could have been better if they’d had equal access to care, equal support, and equal respect. I’ve sat with a 45-year-old Black teacher in Detroit who told me she never got a blood pressure check until she had a heart attack, because her clinic only took appointments during school hours when she was working. I’ve worked with a 52-year-old Indigenous farmer in New Mexico who said he was scared to go to the hospital after a small stroke, because he’d heard stories of family members being dismissed or ignored by doctors. These aren’t failures of the patients—they’re failures of a system that isn’t built to meet their needs.
That’s why this conversation about race and CVD risk can’t be just another topic to put on a clinic agenda. It has to be a core part of how we work, how we design our tools, how we partner with communities, and how we support care teams on the front lines. For our team, that means going beyond just supplying equipment—it means working with clinics to develop tailored programs, advocating for policies that address the root causes of racial health disparities, and listening to patients to learn what they actually need, not what we think they need.

If you’re a care provider, a clinic manager, or a community leader working to address CVD in underserved communities, we want to work with you. We don’t have all the answers, but we have the tools, the partnerships, and the commitment to help you build programs that meet your patients where they are. Whether you need portable screening equipment, virtual monitoring tools, or support setting up community outreach programs, we’re here to collaborate. Let’s work together to make sure that no matter what race or background a person comes from, they get the care they need to keep their heart healthy, to chase their kids, tend their gardens, and live the life they deserve.
Weight Loss References:
Centers for Disease Control and Prevention. (2023). Cardiovascular Disease Disparities.
Journal of the American College of Cardiology. (2022). Redlining and the Availability of Cardiovascular Care in the U.S.
American Heart Association. (2021). Racial and Ethnic Disparities in Hypertension Management.
Circulation. (2020). Food Insecurity and Cardiovascular Disease Risk in U.S. Adults.
Indian Health Service. (2022). Cardiovascular Health of American Indians and Alaska Natives.
Hanzhong Zhengtong International Foreign Trade Co., Ltd.
As one of the most professional cardiovascular suppliers in China, we’re featured by quality products and low price. Please feel free to buy bulk discount cardiovascular in stock here and get quotation from our factory. We also accept customized orders.
Address: No.100, Hanshui lmpression, Wangjiang Road, Hanzhong District, Hanzhong City, Shaanxi Province.
E-mail: zhengtong5120@163.com
WebSite: https://www.hzzt-health.com/